Viewing Company Anthem Inc | StockChase
stockchase picture

Compiling comments that experts make about stocks while on public TV.

Anthem Inc Stock Symbol: ANTM-N

Notes:

Formerly Wellpont Health Networks (WLP-N)

Last Price Recorded: $182.8600 on 2017-09-22

Globe 5 day average
Google Discussions (view only)
yahoo discussion
Bloomberg
Date Signal Expert Opinion Price
2017-09-14 PAST TOP PICK Paul Macdonald

(Top Pick Feb 22/17, Up 17%)  They are a pure play on health insurance in the US.  They are a leader in 14 states on blue cross and blue shield.  Technicians should grin at this chart.


Price:
$186.750
Subject:
HEALTHCARE
Bias:
SELECTIVE
Owned:
Yes
2017-08-01 PAST TOP PICK Alex Ruus

(A Top Pick Sept 6/16. Up 53%.) The number 2 health insurer in the US. They are primarily in 13-14 states and tend to be the #1 provider. Has about a 2% dividend yield. Trading at only around 14X earnings.


Price:
$186.670
Subject:
NORTH AMERICAN
Bias:
UNKNOWN
Owned:
Yes
2017-05-15 TOP PICK Alex Ruus

A great story. The stock has done really well over the last 10 years. The 2nd largest health insurer in the US. It helps to deal with some of the escalating health-care costs problems. Generates gobs and gobs of free cash flow. Trading at about 13X next year’s earnings. Dividend yield of 1.4%. (Analysts’ price target is $191.)


Price:
$182.300
Subject:
NORTH AMERICAN
Bias:
OPTIMISTIC
Owned:
Yes
2017-05-10 PAST TOP PICK Paul Macdonald

(A Top Pick Feb 22/17. Up 39.41%.) He really likes the managed care sector in the US. This is one of the largest Blue Cross-Blue Shield insurance companies. There are some potential rate tailwinds from a tax reform.


Price:
$180.130
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Yes
2017-03-16 TOP PICK Gordon Reid

A US health insurance company. The whole area is in turmoil right now. They insure about 40 million Americans. Even with all of the turmoil, the whole idea from a logical standpoint is that both the Republicans and the Democrats have vowed that they want no one to be left behind, that they want insurance. Ultimately, if insurance is going to work, it has to be very broad. Dividend yield of 1.5%. (Analysts’ price target is $174.)


Price:
$168.420
Subject:
US EQUITIES
Bias:
UNKNOWN
Owned:
Yes
2017-02-22 TOP PICK Paul Macdonald

The dominant licensee of Blue Cross Blue Shield in 14 states. About 1 in 9 Americans have insurance through them. There are some very structural, positive tailwinds for the medical managed care organizations over the next couple of years. Dividend yield of 1.59%. (Analysts’ price target is $175.75.)


Price:
$163.270
Subject:
HEALTHCARE
Bias:
BULLISH on HEALTH CARE
Owned:
Yes
2017-02-21 PAST TOP PICK Alex Ruus

(A Top Pick Feb 2/16. Up 31.82%.) The #2 healthcare insurer in the US. Healthcare has been out of favour in the last year, but even with that this has made decent money. A testament to what a great quality business is. A fantastic cash generating business. Undervalued, trading at 12X 2018 earnings. Dividend increases every year, and they buy back stock.


Price:
$164.220
Subject:
NORTH AMERICAN
Bias:
OPTIMISTIC
Owned:
Yes
2017-01-26 BUY Gordon Reid

A place in the insurance health care space you want to be in until things in that space work out.  Blue Cross/Blue Shield. 


Price:
$152.400
Subject:
US EQUITIES
Bias:
BULLISH
Owned:
Unknown
2017-01-25 COMMENT Dr. Richard Evans

Considers this as a commercial predominant HMO. Most of the lives on this are going to be sponsored by an employer. A fine business. Typically, over time they run on a medical loss ratio, so tend to run over time on the percentage of premiums that come in that are paid out as claims. As Republicans unveil what they want to do in order to replace Obama care, he thinks you will see some issues emerging that threaten some of the companies that take most of their premiums from employers, that is a long-term concern. In the meantime, this should do reasonably well.


Price:
$153.710
Subject:
HEALTHCARE
Bias:
UNKNOWN
Owned:
Unknown
2016-12-05 TOP PICK Alex Ruus

This has been a long term holding for him, and has done really well owning it. He took some profits about 1.5 years ago during the merger mania, when this company announced its merger with Cigna, and since that time you can see the peak, and the stock has tailed off until just recently. The Obama administration were really pushing back against mergers, and there is a much better prospect that the mergers will go forward. The stock is really cheap trading at 12X earnings, and it should trade closer to a market multiple. Dividend yield of 1.8%. (Analysts’ price target is $155.88.)


Price:
$144.090
Subject:
NORTH AMERICAN
Bias:
OPTIMISTIC
Owned:
Yes
2016-10-18 PAST TOP PICK Gordon Reid

(Top Pick Nov 4/15, Down 8.04%) It is down on the threat of a democratic election.  This is the place you want to be in the health care space at this point.  They are large and diversified, adaptable company in this space at attractive valuations of 11 times earnings.


Price:
$123.150
Subject:
US EQUITIES
Bias:
SELECTIVE
Owned:
Yes
2016-10-11 COMMENT Dean Orrico

The deal with Cigna has been an overhang on the stock. A $50 billion acquisition. Having the 2nd and 4th largest players coming together is subject to review by government, and he expects the decision will come early next year. If successful, he thinks the stock will behave nicely and you get a good lift. Even if it is unsuccessful, you probably still get a lift because this uncertainty goes away, and investors will see that management is now getting back to business.


Price:
$121.900
Subject:
HEALTHCARE
Bias:
BULLISH on HEALTH CARE
Owned:
Yes
2016-09-26 BUY Liz Miller

She owns United Healthcare (UNH-N) instead.  She thinks this is an interesting buying opportunity here.  We are seeing a lot of changes in this area and she is looking for a lot of changes in the next 12 months.  If you own it, it is a hold, but you must think three years out. 


Price:
$125.080
Subject:
US EQUITIES
Bias:
BULLISH on US MARKET
Owned:
No
2016-09-06 TOP PICK Alex Ruus

A healthcare stock. Very compelling value. Trading at 10X earnings. The US’s #2 managed care organizational health insurer. One of those good news healthcare stories. They are part of the solution of controlling the healthcare system costs. They work in ratcheting down costs for their members. The buyback on this stock has reduced its shares outstanding by 58% in the last 9 years. Dividend yield of 2%.


Price:
$124.290
Subject:
NORTH AMERICAN
Bias:
OPTIMISTIC
Owned:
Yes
2016-04-21 PAST TOP PICK Alex Ruus

(A Top Pick April 7/15. Down 3.3%.) The #2 healthcare insurer in the US. In the long term, this has been a great performer. Really cheap and has been one of the beneficiaries of Obama care, as well as general healthcare trends. They help the consumer get best healthcare value. Dividend yield of 2% that grows every year. Still a Buy.


Price:
$145.910
Subject:
NORTH AMERICAN
Bias:
OPTIMISTIC
Owned:
Yes
Showing 1 to 15 of 55 entries
<< < 1 2 3 4 > >>

No Comments.


You must be logged in to comment.